Abstract
The early years of the acquired immunodeficiency syndrome (AIDS) epidemic introduced the global medical community to Kaposi’s sarcoma (KS), a heretofore seldom encountered angiosarcomatous neoplasm associated with human herpesvirus-8. At that time, clinicians treating these KS patients were routinely exposed to the pulmonary manifestations of this malignancy, including characteristic airway lesions, peribronchovascular opacities, and the typically hemorrhagic pleural effusions. They also witnessed uncommon complications of pulmonary KS such as chylous effusions, diffuse alveolar hemorrhage, and immune reconstitution inflammatory syndrome. Since the advent of highly active antiretroviral therapy, the incidence of KS has steadily declined and with that so has clinician familiarity with this disease. Herein, we present four KS cases recently encountered at our institution that illustrate both typical manifestations of pulmonary KS as well as its thoracic complications. The case descriptions are followed by a review of these clinical entities with the aim of restoring awareness among frontline physicians of what is now a rare but not quite extinct AIDS-defining neoplasm.
Similar content being viewed by others
Abbreviations
- AIDS:
-
Acquired immunodeficiency syndrome
- BAL:
-
Bronchoalveolar lavage
- CT:
-
Computed tomography
- DAH:
-
Diffuse alveolar hemorrhage
- DKA:
-
Diabetic ketoacidosis
- DNA:
-
Deoxyribonucleic acid
- HAART:
-
Highly active antiretroviral therapy
- HHV-8:
-
Human herpesvirus-8
- HIV:
-
Human immunodeficiency virus
- KS:
-
Kaposi’s sarcoma
- PJP:
-
Pneumocystis jirovecii pneumonia
- WBC:
-
White blood cell
- VL:
-
Viral load
References
Gasparetto TD, Marchiori E, Lourenço S et al (2009) Pulmonary involvement in Kaposi sarcoma: correlation between imaging and pathology. Orphanet J Rare Dis 4:1–7
Engels EA, Pfeiffer RM, Goedert JJ et al (2006) Trends in cancer risk among people with AIDS in the United States 1980–2002. AIDS 20(12):1645–1654
Sgadari C, Monini P, Barillari G et al (2003) Use of HIV protease inhibitors to block Kaposi’s sarcoma and tumour growth. Lancet Oncol 4:537–547
Gallafent JH, Buskin SE, De Turk PB et al (2005) Profile of patients with Kaposi’s sarcoma in the era of highly active antiretroviral therapy. J Clin Oncol 23:1253–1260
Khalil AM, Carette MF, Cadranel JL et al (1995) Intrathoracic Kaposi’s sarcoma. CT findings. Chest 108:1622–1626
Aboulafia DM (2000) The epidemiologic, pathologic, and clinical features of AIDS-associated pulmonary Kaposi’s sarcoma. Chest 117:1128–1145
Naidich DP, Tarras M, Garay SM et al (1989) Kaposi’s sarcoma. CT-radiographic correlation. Chest 96:723–728
Wolff SD, Kuhlman JE, Fishman EK (1993) Thoracic Kaposi sarcoma in AIDS: CT findings. J Assist Tomogr 17:60–62
Fouret PJ, Touboul JL, Mayaud CM et al (1987) Pulmonary Kaposi’s sarcoma in patients with acquired immune deficiency syndrome: a clinicopathological study. Thorax 42:262–268
Garay SM, Belenko M, Fazzini E et al (1987) Pulmonary manifestations of Kaposi’s sarcoma. Chest 91:39–43
Tamm M, Reichenberger F, McGandy CE et al (1998) Diagnosis of pulmonary Kaposi’s sarcoma by detection of human herpes virus 8 in bronchoalveolar lavage fluid. Am J Respir Crit Care Med 157:458–463
Whitby D, Howard MR, Tenant-Flowers M et al (1995) Detection of Kaposi’s sarcoma associated herpesvirus in peripheral blood of HIV-infected individuals and progression to Kaposi’s sarcoma. Lancet 346:799–802
Judson MA, Sahn SA (1994) Endobronchial lesions in HIV-infected individuals. Chest 105:1314–1323
O’Brien RF, Cohn DL (1989) Serosanguinous pleural effusions in AIDS-associated Kaposi’s sarcoma. Chest 96:460–466
Chen Y, Brennessel D, Walters J et al (1999) Human immunodeficiency virus-associated pericardial effusion: report of 40 cases and review of the literature. Am Heart J 137(3):516–521
Pandya K, Lal C, Tuchschmidt J et al (1988) Bilateral chylothorax with pulmonary Kaposi’s sarcoma. Chest 94:1316–1317
Judson MA, Postic B (1990) Chylothorax in a patient with AIDS and Kaposi’s sarcoma. South Med J 83:322–324
Pennington DW, Warnock ML, Stulbarg MS (1990) Chylothorax and respiratory failure in Kaposi’s sarcoma. West J Med 152:421–422
Maradona JA, Carton JA, Asensi V et al (2002) AIDS-related Kaposi’s sarcoma with chylothorax and pericardial involvement satisfactorily treated with liposomal doxorubicin. AIDS 16(5):806–807
Light RW (2013) Chylothorax and Pseudochylothorax. In: Light RW (ed) Pleural Diseases, 6th edn. Lippincott Williams & Wilkins, Philadelphia, pp 412–430
Dib C, Tajik J, Park S et al (2008) Chylopericardium in adults: a literature review over the past decade (1996–2006). J Thorac Cardiovasc Surg 136:650–656
Natrajan S, Hadeli KO, Quan SF (1998) Infected spontaneous chylothorax. Diagn Microbiol Infect Dis 30:31–32
Wang JT, Hsueh PR, Sheng WH et al (2000) Infected chylothorax caused by streptococcus agalactie: a case report. J Formos Med Assoc 99(10):783–784
Kazianis J, Epelbaum O (2011) Chylous empyema or empyematous chylothorax [abstract]? Am J Respir Crit Care Med 183:A6460
Berardino AD, Inchingolo R, Smargiassi A et al (2014) Empyema caused by prevotella bivia complicating an unusual case of spontaneous chylothorax. J Clin Microbiol 52(4):1284–1286
De Lassence A, Fleury-Feith J, Escudier E et al (1995) Alveolar hemorrhage: diagnostic criteria and results in 194 immunocompromised hosts. Am J Respir Crit Care Med 151:157–163
Bais C, Santomasso B, Cosso O et al (1998) G-protein-coupled receptor of Kaposi’s sarcoma-associated herpes virus is a viral oncogene and angiogenesis activator. Nature 391:86–89
Samaniego F, Markham PD, Gendelman R et al (1998) Vascular endothelial growth factor and basic fibroblast growth factor present in Kaposi’s sarcoma (KS) are induced by inflammatory cytokines and synergize to promote vascular permeability and KS lesion development. Am J Pathol 152:1433–1443
Vincent B, Flahault A, Antoine M et al (2001) AIDS-related alveolar hemorrhage. A prospective study of 273 BAL procedures. Chest 120:1078–1084
McKenzie R, Travis WD, Dolan SA et al (1991) The causes of death in patients with human immunodeficiency virus infection: a clinical and pathologic study with emphasis on the role of pulmonary diseases. Medicine (Baltimore) 70:326–343
Alraies MC, Alraiyes AH, Kabach CM et al (2013) Fatal alveolar hemorrhage due to Kaposi sarcoma. QJM 106:961–962
Letang E, Naniche D, Bower M et al (2012) Kaposi sarcoma-associated immune reconstitution syndrome: in need of a specific case definition. CID 55:157–158
Achenbach CJ, Harrington RD, Dhanireddy S et al (2012) Paradoxical immune reconstitution inflammatory syndrome in HIV-infected patients treated with combination antiretroviral therapy after AIDS-defining opportunistic infection. CID 54:424–433
Godoy MCB, Rouse H, Brown JA et al (2007) Imaging features of pulmonary Kaposi sarcoma-associated immune reconstitution syndrome. AJR 189:956–965
Letang E, Almeida JM, Miró JM et al (2010) Predictors of immune reconstitution inflammatory syndrome associated with Kaposi sarcoma in Mozambique: a prospective study. J Acquir Immune Defic Syndr 53:589–597
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflicts of interest
The authors confirm that there are no known conflicts of interest associated with this publication, and there has been no significant financial support for this work that could have influenced its outcome.
Rights and permissions
About this article
Cite this article
Epelbaum, O., Go, R., Patel, G. et al. Pulmonary Kaposi’s Sarcoma and Its Complications in the HAART Era: A Contemporary Case-Based Review. Lung 194, 163–169 (2016). https://doi.org/10.1007/s00408-015-9830-7
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00408-015-9830-7